Literature DB >> 23468130

Inhibition of de novo ceramide biosynthesis by FTY720 protects rat retina from light-induced degeneration.

Hui Chen1, Julie-Thu A Tran2, Annette Eckerd2, Tuan-Phat Huynh2, Michael H Elliott3, Richard S Brush2, Nawajes A Mandal4.   

Abstract

Light-induced retinal degeneration (LIRD) in albino rats causes apoptotic photoreceptor cell death. Ceramide is a second messenger for apoptosis. We tested whether increases in ceramide mediate photoreceptor apoptosis in LIRD and if inhibition of ceramide synthesis protects the retina. Sprague-Dawley rats were exposed to 2,700 lux white light for 6 h, and the retinal levels of ceramide and its intermediary metabolites were measured by GC-MS or electrospray ionization tandem mass spectrometry. Enzymes of the de novo biosynthetic and sphingomyelinase pathways of ceramide generation were assayed, and gene expression was measured. The dosage and temporal effect of the ceramide synthase inhibitor FTY720 on the LIRD retina were measured by histological and functional analyses. Retinal ceramide levels increased coincident with the increase of dihydroceramide at various time points after light stress. Light stress in retina induces ceramide generation predominantly through the de novo pathway, which was prevented by systemic administration of FTY720 (10 mg/kg) leading to the protection of retinal structure and function. The neuroprotection of FTY720 was independent of its immunosuppressive action. We conclude that ceramide increase by de novo biosynthesis mediates photoreceptor apoptosis in the LIRD model and that inhibition of ceramide production protects the retina against light stress.

Entities:  

Keywords:  apoptosis; fingolimod; light-induced retinal degeneration; photoreceptor; sphingomyelinase

Mesh:

Substances:

Year:  2013        PMID: 23468130      PMCID: PMC3646463          DOI: 10.1194/jlr.M035048

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  77 in total

1.  Oral fingolimod (FTY720) for relapsing multiple sclerosis.

Authors:  Ludwig Kappos; Jack Antel; Giancarlo Comi; Xavier Montalban; Paul O'Connor; Chris H Polman; Tomas Haas; Alexander A Korn; Goeril Karlsson; Ernst W Radue
Journal:  N Engl J Med       Date:  2006-09-14       Impact factor: 91.245

Review 2.  FTY720: a most promising immunosuppressant modulating immune cell functions.

Authors:  Zhiren Zhang; Hermann J Schluesener
Journal:  Mini Rev Med Chem       Date:  2007-08       Impact factor: 3.862

3.  Complement factor H: spatial and temporal expression and localization in the eye.

Authors:  Md Nawajes A Mandal; Radha Ayyagari
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-09       Impact factor: 4.799

4.  Protective effect of TEMPOL derivatives against light-induced retinal damage in rats.

Authors:  Masaki Tanito; Feng Li; Michael H Elliott; Mark Dittmar; Robert E Anderson
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-04       Impact factor: 4.799

5.  CTRP5 is a membrane-associated and secretory protein in the RPE and ciliary body and the S163R mutation of CTRP5 impairs its secretion.

Authors:  Md Nawajes A Mandal; Vidyullatha Vasireddy; G Bhanuprakash Reddy; Xiaofei Wang; Sayoko E Moroi; Bikash R Pattnaik; Bret A Hughes; John R Heckenlively; Peter F Hitchcock; Monica M Jablonski; Radha Ayyagari
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-12       Impact factor: 4.799

6.  Spatial and temporal expression of MFRP and its interaction with CTRP5.

Authors:  Md Nawajes A Mandal; Vidyullatha Vasireddy; Monica M Jablonski; Xiaofei Wang; John R Heckenlively; Bret A Hughes; G Bhanuprakash Reddy; Radha Ayyagari
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-12       Impact factor: 4.799

7.  Ceramide production associated with retinal apoptosis after retinal detachment.

Authors:  Marie-Laure Ranty; Stéphane Carpentier; Maxime Cournot; Isabelle Rico-Lattes; François Malecaze; Thierry Levade; Marie-Bernadette Delisle; Jean-Claude Quintyn
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-10-29       Impact factor: 3.117

8.  Finding a way out: lymphocyte egress from lymphoid organs.

Authors:  Susan R Schwab; Jason G Cyster
Journal:  Nat Immunol       Date:  2007-12       Impact factor: 25.606

9.  Curcumin protects retinal cells from light-and oxidant stress-induced cell death.

Authors:  Md Nawajes A Mandal; Jagan M R Patlolla; Lixin Zheng; Martin-Paul Agbaga; Julie-Thu A Tran; Lea Wicker; Anne Kasus-Jacobi; Michael H Elliott; Chinthalapally V Rao; Robert E Anderson
Journal:  Free Radic Biol Med       Date:  2008-12-24       Impact factor: 7.376

10.  Compensational regulation of bHLH transcription factors in the postnatal development of BETA2/NeuroD1-null retina.

Authors:  Jang-Hyeon Cho; William H Klein; Ming-Jer Tsai
Journal:  Mech Dev       Date:  2007-06-12       Impact factor: 1.882

View more
  21 in total

1.  Analysis of sphingolipids in human corneal fibroblasts from normal and keratoconus patients.

Authors:  Hui Qi; Shrestha Priyadarsini; Sarah E Nicholas; Akhee Sarker-Nag; Jeremy Allegood; Charles E Chalfant; Nawajes A Mandal; Dimitrios Karamichos
Journal:  J Lipid Res       Date:  2017-02-10       Impact factor: 5.922

Review 2.  Functional architecture of the retina: development and disease.

Authors:  Mrinalini Hoon; Haruhisa Okawa; Luca Della Santina; Rachel O L Wong
Journal:  Prog Retin Eye Res       Date:  2014-06-28       Impact factor: 21.198

3.  FTY720/fingolimod decreases hepatic steatosis and expression of fatty acid synthase in diet-induced nonalcoholic fatty liver disease in mice.

Authors:  Timothy D Rohrbach; Amon Asgharpour; Melissa A Maczis; David Montefusco; L Ashley Cowart; Pierre Bedossa; Arun J Sanyal; Sarah Spiegel
Journal:  J Lipid Res       Date:  2019-05-20       Impact factor: 5.922

4.  Overexpression of acid ceramidase (ASAH1) protects retinal cells (ARPE19) from oxidative stress.

Authors:  Eriko Sugano; Genea Edwards; Saikat Saha; Lynda A Wilmott; Richard C Grambergs; Koushik Mondal; Hui Qi; Megan Stiles; Hiroshi Tomita; Nawajes Mandal
Journal:  J Lipid Res       Date:  2018-11-09       Impact factor: 5.922

5.  Acid Ceramidase Deficiency in Mice Leads to Severe Ocular Pathology and Visual Impairment.

Authors:  Fabian P S Yu; Benjamin S Sajdak; Jakub Sikora; Alexander E Salmon; Murtaza S Nagree; Jiří Gurka; Iris S Kassem; Daniel M Lipinski; Joseph Carroll; Jeffrey A Medin
Journal:  Am J Pathol       Date:  2018-11-23       Impact factor: 4.307

6.  Analysis of sphingolipid composition in human vitreous from control and diabetic individuals.

Authors:  Lynda A Wilmott; Richard C Grambergs; Jeremy C Allegood; Timothy J Lyons; Nawajes Mandal
Journal:  J Diabetes Complications       Date:  2018-12-14       Impact factor: 2.852

7.  A monophasic extraction strategy for the simultaneous lipidome analysis of polar and nonpolar retina lipids.

Authors:  Todd A Lydic; Julia V Busik; Gavin E Reid
Journal:  J Lipid Res       Date:  2014-05-30       Impact factor: 5.922

8.  Sphingolipid profile alters in retinal dystrophic P23H-1 rats and systemic FTY720 can delay retinal degeneration.

Authors:  Megan Stiles; Hui Qi; Eleanor Sun; Jeremy Tan; Hunter Porter; Jeremy Allegood; Charles E Chalfant; Douglas Yasumura; Michael T Matthes; Matthew M LaVail; Nawajes A Mandal
Journal:  J Lipid Res       Date:  2016-03-05       Impact factor: 5.922

Review 9.  Role of ceramides in the pathogenesis of diabetes mellitus and its complications.

Authors:  Nawajes Mandal; Richard Grambergs; Koushik Mondal; Sandip K Basu; Faiza Tahia; Sam Dagogo-Jack
Journal:  J Diabetes Complications       Date:  2020-09-16       Impact factor: 2.852

10.  Systemic Elevation of n-3 Polyunsaturated Fatty Acids (n-3-PUFA) Is Associated with Protection against Visual, Motor, and Emotional Deficits in Mice following Closed-Head Mild Traumatic Brain Injury.

Authors:  Koushik Mondal; Haruka Takahashi; Jerome Cole; Nobel A Del Mar; Chunyan Li; Daniel J Stephenson; Jeremy Allegood; L Ashley Cowart; Charles E Chalfant; Anton Reiner; Nawajes Mandal
Journal:  Mol Neurobiol       Date:  2021-08-08       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.